MPM BIOIMPACT LLC

Position in CNTX — Context Therapeutics Inc.

CIK 1687078 BOSTON, MA

Position in CNTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$719,671

-$27,260,333 QoQ

Shares Held

1,299,046

-87.8% QoQ

Ownership

1.41%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#13

of 79 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. CNTX ranks #33 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGEM	Cullinan Therapeutics, Inc.	9,731,341	$177,207,719
2	AKTS	Aktis Oncology, Inc.	4,835,872	$155,860,154
3	RVMD	Revolution Medicines, Inc.	492,483	$92,232,216
4	CORT	Corcept Therapeutics Inc	771,028	$67,040,884
5	EWTX	Edgewise Therapeutics, Inc.	1,620,780	$65,852,291
6	TVTX	Travere Therapeutics, Inc.	1,122,731	$63,782,348
7	DBVT	DBV Technologies S.A.	3,666,284	$60,127,057
8	TRVI	Trevi Therapeutics, Inc.	3,073,577	$57,322,211

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$719,671	1,299,046	-87.8%	Shares	Sole	2026-08-14
2026-06-30	$719,671	1,299,046	-87.8%	Shares	Sole	2026-08-14
2026-03-31	$27,980,004	10,679,391	0.0%	Shares	Sole	2026-05-15
2025-12-31	$15,698,704	10,679,391	-27.4%	Shares	Sole	2026-02-17
2025-12-31	$15,698,704	10,679,391	-27.4%	Shares	Sole	2026-02-17
2025-09-30	$14,249,999	14,705,882	0.0%	Shares	Sole	2025-11-14
2025-06-30	$9,632,352	14,705,882	0.0%	Shares	Sole	2025-08-14
2025-03-31	$8,999,999	14,705,882	0.0%	Shares	Sole	2025-05-15
2024-12-31	$15,441,176	14,705,882	—	Shares	Sole	2025-02-14
2024-12-31	$15,441,176	14,705,882	—	Shares	Sole	2025-01-08
No filing history on record for this holder in this stock.